Does active smoking really influence the course of Crohn's disease? A retrospective observational study

Journal of Crohn's and Colitis

Volumn 7, Issue 4, 2013, Pages 280-285

  Zabana, Yamile ^a,d   Garcia Planella, Esther ^b   Van Domselaar, Manuel ^c   Mañosa, Míriam ^a,d   Gordillo, Jordi ^b   López San Román, Antonio ^c   Cabré, Eduard ^a,d   Domènech, Eugeni ^a,d  

^a HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

^b HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

^c HOSPITAL RAMÓN Y CAJAL   (Spain)

^d INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

Crohn's disease; Disease evolution; Inflammatory bowel disease; Smoking; Surgery; Therapy

Indexed keywords

IMMUNOMODULATING AGENT;

ADULT; ARTICLE; CLINICAL FEATURE; CROHN DISEASE; FEMALE; FOLLOW UP; HUMAN; INTESTINE RESECTION; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; OBSERVATIONAL STUDY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SMOKING;

ADULT; CROHN DISEASE; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; SMOKING; SMOKING CESSATION; TREATMENT OUTCOME;

EID: 84875265594     PISSN: 18739946     EISSN: 18764479     Source Type: Journal    
DOI: 10.1016/j.crohns.2012.03.020     Document Type: Article

References (31)

1. Podolsky D. Inflammatory bowel disease. N Engl J Med 2002, 347:417-429.
2. Lindberg E., Tysks C., Andersson K., Järnerot G. Smoking and inflammatory bowel disease, a case control study. Gut 1988, 29:352-357.
3. Mahid S., Minor K., Soto R., Hornung C.A., Galandiuk S. Smoking and inflammatory bowel disease: a meta-analysis. Mayo Clin Proc 2006, 81:1462-1471.
4. Duffy L.C., Zielezny M.A., Marshall J.R., Weiser M.M., Byers T.E., Phillips J.P., et al. Cigarette smoking and risk of clinical relapse in patients with Crohn's disease. Am J Prev Med 1990, 6:161-166.
5. Russell M.G., Nieman F.H., Bergers J.M., Stockbrügger R.W. Cigarette smoking and quality of life in patients with inflammatory bowel disease. Eur J Gastroenterol 1996, 8:1075-1081.
6. Lindberg E., Jarnerot G., Huitfeldt B. Smoking in Crohn's disease: effect on localization and clinical course. Gut 1992, 33:779-782.
7. Cosnes J., Carbonnel F., Beaugerie L., Le Quintrec Y., Gendre J.P. Effects of smoking on the long term course of Crohn's disease. Gastroenterology 1996, 110:424-431.
8. Sutherland L.R., Ramcharan S., Bryant H., Fick G. Effect of cigarette smoking on recurrence of Crohn's disease. Gastroenterology 1990, 98:1123-1128.
9. Papay P., Reinisch W., Ho E., Gratzer C., Lissner D., Herkner H., et al. The impact of thiopurines on the risk of surgical recurrence in patients with Crohn's disease after first intestinal surgery. Am J Gastroenterol 2010, 105(5):1158-1164.
10. Cosnes J., Carbonnel F., Carrat F., Beaugerie L., Cattan S., Gendre J. Effects of current and former cigarette smoking on the clinical course of Crohn's disease. Aliment Pharmacol Ther 1999, 12:1403-1411.
11. Cottone M., Rosselli M., Orlando A., Puleo A., Cappello M., Traina M., et al. Smoking habits and recurrence in Crohn's disease. Gastroenterology 1994, 106:643-648.
12. Cosnes J., Beaugerie L., Carbonnel F., Gendre J.P. Smoking cessation and the course of Crohn's disease: an intervention study. Gastroenterology 2001, 120:1093-1099.
13. Cosnes J., Nion-Larmurier I., Afchain P., Beaugerie L., Gendre J.P. Clin Gastroenterol Hepatol 2004, 2:41-48.
14. Fidder H.H., Avidan B., Lahav M., Bar-Meir S., Chowers Y. Clinical and demographic characterization of Jewish Crohn's disease patients in Israel. J Clin Gastroenterol 2003, 36:8-12.
15. Lakatos P.L., Szalay F., Tulassay Z., Molnar T., Kovacs A., Gasztonvi B., et al. Clinical presentation of Crohn's disease. Association between familial disease, smoking, disease phenotype, extraintestinal manifestations and need for surgery. Hepatogastroenterology 2005, 52:817-822.
16. Aldhous M.C., Drummond H., Anderson N., Smith L.A., Arnott I.D., Satsangi J. Does cigarette smoking influence the phenotype on Crohn's disease? Analysis using the Montreal classification. Am J Gastroenterol 2007, 102:577-588.
17. Louis E., Michel V., Hugot J.P., Reenaers C., Fontaine F., Delforge M., et al. Early development of stricturing or penetrating pattern in Crohn's disease is influenced by disease location, number of flares, and smoking but not by NOD2/CARD15 genotype. Gut 2003, 52:552-557.
18. Smith B.R.K., Arnott I.D.R., Drummond H.E., Nimmo E.R., Satsangi J. Disease location, anti-Saccharomyces cerevisiae antibody, and NOD2/CARD15 genotype influence the progression of disease behavior in Crohn's disease. Inflamm Bowel Dis 2004, 10:521-528.
19. Lennard-Jones J.E. Classification of inflammatory bowel disease. Scand J Gastroenterol 1989, 24(Suppl. 170):2-6.
20. Silverberg M.S., Satsangi J., Ahmad T., Arnott I.D., Bernstein C.N., Brant S.R., et al. Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a Working Party of the 2005 Montreal World Congress of Gastroenterology. Can J Gastroenterol 2005, 19(Suppl. A):5-36.
21. Jones D., Osterman M., Bewtra M., Lewis J.D. Passive smoking and inflammatory bowel disease: a meta-analysis. Am J Gastroenterol 2008, 103:2382-2393.
22. Gasche C., Scholmerich J., Brynskov J., Brynskov J., D'Haens G., Hanauer S.B., et al. A simple classification of Crohn's disease: report of the Working Party for the World Congresses of Gastroenterology, Vienna 1998. Inflamm Bowel Dis 2000, 6:8-15.
23. Cosnes J. Tobacco and IBD: relevance in the understanding of disease mechanisms and clinical practice. Best Pract Res Clin Gastroenterol 2004, 18:481-496.
24. Russel M.G., Volovics A., Schoon E.J., van Wijlick E.H., Logan R.F., Shivananda S., et al. Inflammatory bowel disease: is there any relation between smoking status and disease presentation. Inflamm Bowel Dis 1998, 4:182-186.
25. Cosnes J., Cattan S., Blain A., Beaugerie L., Carbonnel F., Parc R., et al. Long-term evolution of disease behavior of Crohn's disease. Inflamm Bowel Dis 2002, 8:244-250.
26. Lakatos P., Czegledi Z., Szamosi T., Banai J., David G., Zsigmond F., et al. Perianal disease, small bowel disease, smoking, prior steroid or early azathioprine/biological therapy are predictors of disease behavior change in patients with Crohn's disease. World J Gastroenterol 2009, 15:3504-3510.
27. Risch N. Dissecting racial and ethnic differences. N Engl J Med 2006, 354:408-411.
28. Roth M.P., Petersen G.M., McElree C., Feldman E., Rotter J.I. Geographic origins of Jewish patients with inflammatory bowel disease. Gastroenterology 1989, 97:900-904.
29. Reddy S.I., Burakoff R. Inflammatory bowel disease in African Americans. Inflamm Bowel Dis 2003, 9:380-385.
30. Probert C.S., Jayanthi V., Hughes A.O., Thompson J.R., Wicks A.C., Mayberry J.F. Prevalence and family risk of ulcerative colitis and Crohn's disease: an epidemiological study among Europeans and south Asians in Leicestershire. Gut 1993, 34:1547-1551.
31. Domènech E., Carrión S., Garcia-Planella E., Mañosa M., Gordillo J., Concepción M., et al. Smoking status and response to thiopurines in steroid-dependent inflammatory bowel disease. Inflamm Bowel Dis 2010, 17(4):971-975.